Login / Signup

Integrated profiling identifies caveolae-associated protein 1 as a prognostic biomarker of malignancy in glioblastoma patients.

Qing GuoGe-Fei GuanWen ChengCun-Yi ZouChen ZhuPeng ChengAn-Hua Wu
Published in: CNS neuroscience & therapeutics (2018)
We identified CAVIN1 as a prognostic biomarker and potential target for developing novel therapeutic strategies against GBM.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • chronic kidney disease
  • newly diagnosed
  • peritoneal dialysis
  • genome wide
  • gene expression
  • patient reported outcomes
  • risk assessment
  • dna methylation